Cited by 117Liver physiology and pathologyDevelopmental Biology and Gene RegulationCongenital heart defects research

Tbx3 promotes liver bud expansion during mouse development by suppression of cholangiocyte differentiation†

Open access
Lüdtke, Timo H.‐W., Christoffels, Vincent M., Petry, Marianne, Kispert, Andreas·2009·Hepatology

Abstract

UNLABELLED: After specification of the hepatic endoderm, mammalian liver organogenesis progresses through a series of morphological stages that culminate in the migration of hepatocytes into the underlying mesenchyme to populate the hepatic lobes. Here, we show that in the mouse the transcriptional repressor Tbx3, a member of the T-box protein family, is required for the transition from a hepatic diverticulum with a pseudo-stratified epithelium to a cell-emergent liver bud. In Tbx3-deficient embryos, proliferation in the hepatic epithelium is severely reduced, hepatoblasts fail to delaminate, and cholangiocyte rather than hepatocyte differentiation occurs. Molecular analyses suggest that the primary function of Tbx3 is to maintain expression of hepatocyte transcription factors, including hepatic nuclear factor 4a (Hnf4a) and CCAAT/enhancer binding protein (C/EBP), alpha (Cebpa), and to repress expression of cholangiocyte transcription factors such as Onecut1 (Hnf6) and Hnf1b. CONCLUSION: Tbx3 controls liver bud expansion by suppressing cholangiocyte and favoring hepatocyte differentiation in the liver bud.

AI snapshot

Written from the paper’s full text.

TL;DR

Tbx3 is required for the transition from the mouse hepatic diverticulum to an expanding liver bud. Loss of Tbx3 reduces hepatoblast proliferation and migration and redirects differentiation toward cholangiocytes by maintaining hepatocyte factors Hnf4a/Cebpa and suppressing cholangiocyte factors Onecut1/Hnf1b.

Key findings

  • Tbx3-deficient embryos on an NMRI background survived until E14.5 but had a disproportionately small, blood-filled liver; Afp and albumin were dramatically reduced, while Ck18 was increased and detected in 10% to 20% of mutant liver cells.
  • Hepatic specification occurred normally at E9.0, but at E9.5 mutant hepatic epithelium lacked wild-type protrusions and delaminations; BrdU labeling in mutant hepatic endoderm reached only half the wild-type level, while apoptosis was unaffected.
  • At E9.5, Tbx3-mutant liver buds showed down-regulation of Cebpa and Hnf4a and up-regulation of Onecut1 and Hnf1b; Prox1 was normal at E9.0 but severely down-regulated at E9.5, and E-cadherin remained high with an intact laminin-rich basal lamina.
  • In cell culture, Tbx3 overexpression increased Hnf4a and Cebpa, dominant-negative Tbx2-VP16 reduced Hnf4a, Cebpa, and albumin, and Onecut1 repressed Hnf4a/Cebpa and, with Tbx2-VP16, activated the cholangiocyte marker Ck7; p19 Arf levels were unaffected.

Methods

  • Mice carrying a Tbx3 null allele (Tbx3cre) were maintained on an outbred NMRI background; timed pregnancies were used, and embryos were analyzed by histology, immunofluorescence, and in situ hybridization.
  • Proliferation was assessed by BrdU incorporation at E9.0 and E9.5 using nine sections from three individual embryos per genotype and time point, with two-tailed Student t test and significance at P < 0.05; apoptosis was assessed by TUNEL at E9.5.
  • Overexpression experiments used the bipotential mouse embryonic liver cell line 9A1 and murine hepatoma Hepa1-6 cells transfected with Tbx3, Tbx2-VP16, Onecut1, or Hnf1b constructs, followed by semiquantitative RT-PCR or qRT-PCR for hepatocyte, cholangiocyte, and cell-cycle markers.

Limitations

  • Stated: the authors cannot resolve the discrepancy between regulation of Onecut1 by Tbx3 in vivo and in vitro; they suggest the cellular system may be inadequate because of missing cofactors present in the early liver bud.
  • Stated: there is no molecular evidence for direct regulation of Onecut1 by Tbx3, and the molecular mediators of the proliferation phenotype remain unknown.
  • Stated: future conditional ablation of Tbx3 at later time points is needed to analyze its role in liver development and homeostasis. Evident from the text: the conclusions rely on mouse mutants and two cell lines, without direct binding or chromatin evidence for the proposed transcriptional relationships.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1002/hep.22700

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 29 cited sources checked · 0 supported · 0 flagged

  • Findingown data

    In Tbx3-/- embryos at E9.0, the ventral foregut endoderm expresses Afp indistinguishably from wild-type.

    “In Tbx3 Ϫ/Ϫ embryos of E9.0 (16-somite stage), the ventral foregut endoderm expressed Afp indistinguishably from the wild-type”
    Quote in the paperSubstantial claim
  • Findingown data

    Tbx3-deficient livers at E14.5 show a dramatic reduction of Afp and albumin expression.

    “Tbx3-deficient livers were characterized by a dramatic reduction of the hepatoblast marker gene alpha fetoprotein (Afp) and the hepatocyte marker gene albumin (Fig. 1C)”
    Quote in the paperSubstantial claim
  • Findingown data

    In Tbx3-/- embryos on an NMRI outbred background, homozygous mutant embryos are viable until E14.5.

    “we maintained a new Tbx3 null allele (Tbx3 cre ) 7 on an NMRI outbred background that supported viability of homozygous mutant embryos until E14.5.”
    Quote in the paperSubstantial claim
  • Findingown data

    At E12.5, dramatic reduction of Afp-positive cells confirmed the complete failure to expand the hepatic cell population in the mutant.

    “Dramatic re-duction of Afp-positive cells at E12.5 confirmed the complete failure to expand this hepatic cell population in the mutant.”
    Quote in the paperSubstantial claim
  • Findingown data

    At E10.5, few Afp-positive cells were found in the underlying mesenchyme of the mutant compared to the densely populated wild-type.

    “At E10.5 the mesenchyme adjacent to the liver bud was densely populated with hepatoblasts in the wild-type, whereas few Afp-positive cells were found in the underlying mesenchyme of the mutant.”
    Quote in the paperSubstantial claim
  • May combine two claims. 35
  • The quote only partly states this claim. 2
  • Classified as probably not a substantial claim. 19
  • May combine two claims.

    Findingown data

    At E9.5, the mutant hepatic epithelium appeared thickened but lacked the characteristic wild-type protrusions and delaminations.

    “At E9.5, the mutant hepatic epithelium appeared thickened but lacked the characteristic wild-type protrusions and delaminations.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    At E14.5, Tbx3-/- embryos show an overall size reduction and a disproportionately small liver filled with blood cells.

    “At this stage, Tbx3 Ϫ/Ϫ embryos showed an overall size reduction and a disproportionately small liver that was filled with blood cells (Fig. 1A, B).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The hepatic primordium failed to expand and to delaminate hepatoblasts into the underlying mesenchyme in Tbx3-/- embryos.

    “However, the hepatic primordium failed to expand and to delaminate hepatoblasts into the underlying mesenchyme.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Tbx3 expression is strongly up-regulated at the 23-somite stage (E9.5) and completely overlaps Afp expression in the liver bud.

    “Tbx3 expression was strongly up-regulated at the 23somite stage (E9.5) and completely overlapped expression of Afp in the liver bud.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The proliferation rate in the mutant hepatic endoderm at E9.5 reached only half of the wild-type level and was severely decreased compared to the adjacent foregut endoderm.

    “The proliferation rate in the mutant hepatic endoderm reached only half of the wild-type level and was severely decreased in comparison with the adjacent foregut endoderm.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In Tbx3-deficient liver bud epithelium, Hnf4a, Cebpa, and albumin are down-regulated, and Onecut1, Hnf1b, and CK18 are up-regulated at later stages.

    “We found changes in the gene expression pattern of the epithelium of the Tbx3-deficient liver bud, including down-regulation of Hnf4a, Cebpa, and the hepatocyte marker albumin, and up-regulation of Onecut1, Hnf1b, and the biliary marker CK18 at later stages”
    • Also stated in: § Proliferation and Migration Defects in the Tbx3-Deficient Liver Bud Are Secondary to Cell Fate Changes. · plain
      “Expression of Cebpa and Hnf4a is down-regulated, One-cut1 and Hnf1b expression is upregulated in the E9.5 Tbx3 Ϫ/Ϫ liver bud”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    E-cadherin remained high in the hepatic epithelium at the 30s-stage, and the basal lamina that surrounded it stayed intact in Tbx3 mutant.

    “E-cadherin remained high in the hepatic epithelium at the 30s-stage, and the basal lamina that surrounded it stayed intact (Fig. 5A).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Expression of Prox1 in the Tbx3-/- hepatic epithelium was unchanged at E9.0 but severely down-regulated at E9.5.

    “Expression of Prox1 in the Tbx3 Ϫ/Ϫ hepatic epithelium was unchanged at E9.0 but severely down-regulated at E9.5 (Fig. 5B).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Proliferation in the lateral and dorsal foregut endoderm was higher than in the hepatic endoderm at E9.0 but was not significantly altered between genotypes.

    “Proliferation in the lateral and dorsal foregut endoderm was higher than that in the hepatic endoderm at this stage but, as expected, was not significantly altered between the two genotypes.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Expression of c-Met in the hepatic endoderm and Hgf in the underlying mesenchyme was unaltered in the mutant.

    “Expression of c-Met in the hepatic endoderm, and of Hgf in the underlying mesenchyme was unaltered in the mutant.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    In E9.5 wildtype hepatic epithelium, Hnf4a and Cebpa were strongly expressed, whereas Onecut1, Onecut2, and Hnf1b were not detected.

    “In the hepatic epithelium of E9.5 wildtype embryos, hepatocyte genes Hnf4a and Cebpa were strongly expressed, whereas expression of Onecut1, One-cut2, and Hnf1b was not detected”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Expression of c-Myc, Ccnd1, and Foxm1 was similarly unaffected in the mutant.

    “Expression of the proto-oncogene c-Myc, and of the genes encoding the cell cycle regulator cyclin D1 (Ccnd1) and the forkhead transcription factor Foxm1 were similarly unaffected”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    In E9.5 Tbx3-/- hepatic epithelium, Cebpa and Hnf4a are down-regulated and Hnf1b and Onecut1 are up-regulated.

    “Downregulation of Cebpa and Hnf4a and up-regulation of Hnf1b and Onecut1 expression in the Tbx3 Ϫ/Ϫ hepatic epithelium”
    • Also stated in: § Hepatic Differentiation Defects in Tbx3 · boosted
      “QRT-PCR analysis on mRNA obtained from E9.5 liver buds independently confirmed the observed changes of expression (Fig. 6B).”
    • Also stated in: § Tbx3 and Onecut1 Antagonistically Regulate Hepatobiliary Fate Decision. · plain
      “Expression of Cebpa and Hnf4a is down-regulated, One-cut1 and Hnf1b expression is upregulated in the E9.5 Tbx3 Ϫ/Ϫ liver bud”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In Tbx3 mutant embryos, hepatic cords did not protrude from the liver bud, and hepatoblasts failed to invade the underlying septum transversum mesenchyme.

    “In Tbx3mutant embryos, hepatic cords did not protrude from the liver bud, and hepatoblasts failed to invade the underlying septum transversum mesenchyme.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    At E9.0, Cebpa and Hnf4a were expressed in the hepatic endoderm, whereas Onecut1, Onecut2, and Hnf1b were hardly detected.

    “At E9.0, Cebpa and Hnf4a were expressed in the hepatic endoderm, whereas expression of Onecut1, Onecut2, and Hnf1b was hardly detected.”
    Quote in the paperSubstantial claim
  • The quote only partly states this claim.

    Findingown data

    Transfection of a Onecut1 expression construct in 9A1 hepatoblasts resulted in downregulation of Hnf4a and Cebpa.

    “Transfection of a Onecut1 expression construct similarly resulted in downregulation of Hnf4a and Cebpa (Fig. 7A).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In E9.5 Tbx3-/- liver bud, Cebpa and Hnf4a are down-regulated, and Onecut1 and Hnf1b are upregulated.

    “Expression of Cebpa and Hnf4a is down-regulated, One-cut1 and Hnf1b expression is upregulated in the E9.5 Tbx3 Ϫ/Ϫ liver bud”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In the Tbx3-mutant liver bud, proliferation is reduced and hepatocyte growth factor-alpha, cyclin D1, and Foxm1 expression is unchanged.

    “Yet, proliferation in the Tbx3-mutant liver bud is reduced and hepatocyte growth factor-alpha, cyclin D1, and Foxm1 expression was unchanged.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Onecut1 down-regulates hepatocyte markers and up-regulates the cholangiocyte marker gene Ck7 in combination with Tbx2-VP16.

    “whereas Onecut1 down-regulates hepatocyte markers and up-regulates in combination with Tbx2-VP16 the cholangiocyte marker gene Ck7.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Tbx3 enhances and maintains hepatocyte marker expression.

    “Tbx3 enhances and maintains hepatocyte marker expression”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Cotransfection of Onecut1 in Hepa1-6 cells further represses Hnf4a expression and activates Ck7.

    “Cotransfection of Onecut1 in these cells further repressed Hnf4a expression and activated the cholangiocyte differentiation marker Ck7”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Mutant livers are still encapsulated and of normal shape but dramatically reduced in size.

    “Mutant livers are still encapsulated and of normal shape but dramatically reduced in size.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Prox1 expression is established normally in Tbx3-/- embryos but declines dramatically from E9.5.

    “Intriguingly, Prox1 expression was established normally in Tbx3 Ϫ/Ϫ embryos, but expression dramatically declined from E9.5 on.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Proliferation rates differ significantly between wild-type and mutant in the hepatic endoderm but remain similar in the foregut endoderm devoid of Tbx3 expression at E9.5.

    “Proliferation rates between wild-type and mutant differ significantly in the hepatic endoderm but remain similar in the foregut endoderm that is devoid of Tbx3 expression at E9.5.”
    Quote in the paperSubstantial claim
  • The quote only partly states this claim.

    Findingown data

    Prox1 expression is severely down-regulated at the 25-somite stage in Tbx3 mutant.

    “Prox1 expression is severely down-regulated at the 25-somite stage.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Findingnone given

    Onecut1 is up-regulated in Tbx3-overexpressing cells.

    “the up-regulation of One-cut1 in Tbx3-overexpressing cells seems to contradict this assumption.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationcitation

    The Tbx3-/- liver phenotype mimics Prox1-/- animals, suggesting an epistatic relation between Tbx3 and Prox1 in liver development.

    “This phenotype mimics the findings in Prox1 Ϫ/Ϫ animals 16 and suggested an epistatic relation between the two genes in liver development.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [16]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Classified as probably not a substantial claim.

    Premisecitation

    Cebpa and Hnf4a encode transcription factors involved in the early stages of hepatocyte differentiation.

    “CCAAT/enhancer binding protein (C/EBP), alpha (Cebpa) and hepatic nuclear factor 4a (Hnf4a) encode transcription factors that are involved in the early stages of hepatocyte differentiation, [17][18][19]”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites [17]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [18]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [19]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Heterozygosity of TBX3 causes Ulnar-mammary syndrome in humans.

    “Heterozygosity of TBX3 causes Ulnar-mammary syndrome in humans, an autosomal-dominant disorder characterized by upper limb skeletal malformations, severe hypoplasia of the breast, and hair and genital defects.4”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [4]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Interpretationnone given

    Tbx3 maintains the hepatocyte lineage and suppresses the cholangiocyte lineage by antagonistically regulating expression of transcription factor genes required for either differentiation pathway.

    “We propose that Tbx3 maintains the hepatocyte and suppresses the cholangiocyte lineage by antagonistically regulating expression of transcription factor genes required for either differentiation pathway.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    The primary function of Tbx3 is to maintain expression of hepatocyte transcription factors including Hnf4a and Cebpa, and to repress expression of cholangiocyte transcription factors such as Onecut1 and Hnf1b.

    “Molecular analyses suggest that the primary function of Tbx3 is to maintain expression of hepatocyte transcription factors, including hepatic nuclear factor 4a (Hnf4a) and CCAAT/enhancer binding protein (C/EBP), alpha (Cebpa), and to repress expression of cholangiocyte transcription factors such as Onecut1 (Hnf6) and Hnf1b.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    Tbx3 is required to maintain and enhance hepatocyte differentiation.

    “This supports the in vivo analysis and suggests that Tbx3 is required to maintain and enhance hepatocyte differentiation.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Targeted mutations have demonstrated the requirement for the genes encoding Hgf and c-Met for proliferation or survival of hepatocytes.

    “Targeted mutations have demonstrated the requirement for the genes encoding hepatocyte growth factor (Hgf ) and its receptor c-Met for proliferation or survival of hepatocytes.12”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [12]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    A total of nine sections from three individual embryos per genotype and time point were used for quantification.

    “A total of nine sections from three individual embryos per genotype and time point were used for quantification.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    Onecut1 (Hnf6), Onecut2, and Hnf1b control cholangiocyte differentiation.

    “whereas the transcriptional regulators Onecut1 (Hnf6), Onecut2, and Hnf1b control cholangiocyte differentiation.[20][21][22]”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites [20]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [21]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [22]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Interpretationown data

    Tbx3 controls liver bud expansion by suppressing cholangiocyte and favoring hepatocyte differentiation in the liver bud.

    “Conclusion: Tbx3 controls liver bud expansion by suppressing cholangiocyte and favoring hepatocyte differentiation in the liver bud.”
    • Also stated in: § Hepatic Differentiation Defects in Tbx3 · hedged
      “Together these findings suggest that Tbx3 controls hepatic development by suppressing cholangiocyte and favoring hepatocyte differentiation in the liver bud at E9.5 (Fig. 6C).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Assays were performed at least twice in duplicate.

    “Assays were performed at least twice in duplicate, and statistical analysis was done as described previously.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Extrahepatic expression domains confirmed the quality of probes and experimental conditions.

    “although extrahepatic expression domains confirmed the quality of probes and experimental conditions.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing), S4 (based).

    Premisecitation

    Hematopoietically expressed homeobox regulates the transition from a columnar to a pseudostratified epithelium.

    “Expression of hematopoietically expressed homeobox that regulates the transition from a columnar to a pseudostratified epithelium 13 was unchanged”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [13]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Classified as probably not a substantial claim.

    Premisecitation

    Both hepatocytes and cholangiocytes derive from a bipotential precursor cell, the hepatoblast.

    “Both cell types derive from a bipotential precursor cell, the hepatoblast, whose specification, expansion, and differentiation is intimately linked with morphogenesis of the liver. 1”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [1]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given

    Tbx3-homozygous mice present ulnar-mammary syndrome-related features, including severe defects in limb and mammary gland development.

    “Tbx3-homozygous mice present ulnar-mammary syndrome-related features, including severe defects in limb and mammary gland development.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    In Prox1 mutant mice, proliferation of hepatoblasts is decreased and delamination from the hepatic diverticulum is disturbed.

    “In Prospero-related homeobox 1 (Prox1) mutant mice, proliferation of hepatoblasts is decreased and delamination from the hepatic diverticulum is disturbed.16”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [16]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Interpretationown data

    Cholangiocyte differentiation is prevented by repression of Onecut1 (and its target Hnf1b), whereas Cebpa and Hnf4a expression is maintained, leading to differentiation of hepatocytes with high proliferation and migration potential.

    “Cholangiocyte differentiation is prevented by repression of Onecut1 (and its target Hnf1b), whereas Cebpa and Hnf4a expression is maintained, leading to differentiation of hepatocytes with their high proliferation and migration potential.”
    • Also stated in: § Proliferation and Migration Defects in the Tbx3-Deficient Liver Bud Are Secondary to Cell Fate Changes. · plain
      “Cholangiocyte differentiation is prevented by repression of Onecut1 (and its target Hnf1b), whereas Cebpa and Hnf4a expression is maintained, leading to differentiation of hepatocytes with their high proliferation and migration potential.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    Tbx3 does not establish Prox1 expression but is indirectly required for its maintenance.

    “Hence, Tbx3 does not establish Prox1 expression but is indirectly required for its maintenance.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Onecut1/Cebpa binary complex activates Foxa2 transcription.

    “as shown before for the activation of Foxa2 transcription by a One-cut1/Cebpa binary complex.34”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [34]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Classified as probably not a substantial claim.

    Premisecitation

    Cebpa suppresses cholangiocyte differentiation.

    “the known role of Cebpa as a suppressor of cholangiocyte differentiation.28”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [28]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Prox1 remains continuously expressed in hepatocytes but is lost from cholangiocytes.

    “Because Prox1 remains continuously expressed in hepatocytes but is lost from cholangiocytes, 31”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [31]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Cholangiocytes derive from a group of hepatoblasts located in proximity to the portal vein.

    “cholangiocytes derive from a group of hepatoblasts located in proximity to the portal vein.26,27”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [26]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [27]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Forced expression of Onecut1 stimulates hepatocyte proliferation and increases expression of hepatocyte growth factor-alpha, cyclin D1, and Foxm1 in mature hepatocytes.

    “It was previously shown that forced expression of One-cut1 stimulates hepatocyte proliferation and leads to increased expression of hepatocyte growth factor-alpha, cyclin D1, and Foxm1 in mature hepatocytes.33”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [33]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Differentiation of hepatoblasts into hepatocytes and bile duct cells is temporally and spatially separated during liver development.

    “Differentiation of hepatoblasts in hepatocytes and bile duct cells is temporally and spatially separated during liver development.”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [26]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [27]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Prox1 suppresses gallbladder-specific genes.

    “The fact that Prox1 suppresses gallbladder-specific genes may further contribute to or reinforce cholangiocyte differentiation in Tbx3 mutants.32”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [32]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    In Oc1/Oc2 double mutants, the basal lamina surrounding the liver bud remains intact and hepatoblasts fail to delaminate from the epithelium.

    “In Oc1/Oc2 double mutants, the basal lamina surrounding the liver bud remains intact, and hepatoblasts fail to delaminate from the epithelium.21”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [21]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Onecut2 is a direct target of the T-domain protein Tbet.

    “the closely related gene Onecut2 is a direct target of the T-domain protein Tbet, 30”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [30]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

53 of 53
  • The paper relies on this without support.

    Tbx2-VP16 competes with Tbx3 for the same conserved DNA binding sites and activates transcription, thus acting as a dominant negative version of the transcriptional repressor Tbx3.

    “Tbx2-VP16 competes with Tbx3 for the same conserved DNA binding sites and activates transcription, thus acting as a dominant negative version of the transcriptional repressor Tbx3.”
  • The authors state this as an assumption.

    Severe reduction of cellular proliferation in the hepatic epithelium at E9.5 is a consequence of the failure to maintain Cebpa and Hnf4a expression, and thus hepatocyte fate.

    “We assume that severe reduction of cellular proliferation in the hepatic epithelium at E9.5 is a consequence of the failure to maintain Cebpa and Hnf4a expression, and thus hepatocyte fate.”
2 of 2

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lüdtke, T. H. ‐., Christoffels, V. M., Petry, M., & Kispert, A.
Affiliations
  • Medizinische Hochschule Hannover (DE)
  • Amsterdam UMC Location University of Amsterdam (NL)
Corresponding author
Kispert, Andreas
Venue
Hepatology
Published
2009-03
Volume
49
Issue
3
Pages
969-978
ISSN
0270-9139 (ISSN-L)
OpenAlex
W2027916006
Cited by
117
References
35
Citations by year
2026: 3 · 2025: 5 · 2024: 1 · 2023: 2 · 2022: 6 · 2021: 9 · 2020: 12 · 2019: 6 · 2018: 8 · 2017: 7 · 2016: 6 · 2015: 8 · 2014: 6 · 2013: 8 · 2012: 3
FWCI
5.71
Type
journal article
Language
en
Open access
Locations
  • Hepatology (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
Deutsche Forschungsgemeinschaft
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
Keywords
TBX3, liver organogenesis, cholangiocyte differentiation, hepatocyte differentiation, hepatocyte proliferation, HNF4α, CEBPA, HNF6, HNF1B, transcriptional repression, mouse embryo
MeSH terms
Animals, Cell Differentiation, Epithelial Cells, Female, Liver, Pregnancy, Bile Ducts, Extrahepatic, Mice, Knockout, Cyclin-Dependent Kinase Inhibitor p16, T-Box Domain Proteins, CCAAT-Enhancer-Binding Proteins, Organogenesis, Cell Proliferation, Mice, Hepatocyte Nuclear Factor 1-beta, Hepatocyte Nuclear Factor 4, Hepatocyte Nuclear Factor 6

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-23.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-23.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review